These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8108339)

  • 1. [Effect of azathioprine on immunologic parameters in patients with newly diagnosed insulin-dependent diabetes mellitus].
    Shamkhalova MSh; Abugova IA; Shishko PI; Dedov II; Kozlov LV; Aleshkin VA; Rozina MN
    Probl Endokrinol (Mosk); 1993; 39(5):16-20. PubMed ID: 8108339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parameters of cellular and humoral immunity in patients with diabetes mellitus in the early stages of disease development; experience in treatment with the immunosuppressant azathioprine].
    Dedov II; Abugova IA; Shishko PI; Shamkhalova MSh
    Probl Endokrinol (Mosk); 1993; 39(1):3-7. PubMed ID: 8058658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of disorders of cellular and humoral immunity parameters in patients with insulin-dependent diabetes mellitus].
    Khaitov RM; Dedov II; Brykova SV; Smirnova OM; Esenin VI; Andreev VN; Nikonova TV; Kireeva AP; Gudima GO; Alekseev LP
    Probl Endokrinol (Mosk); 1992; 38(2):8-12. PubMed ID: 1513781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.
    Moncada E; Subirá ML; Oleaga A; Goñi F; Sánchez-Ibarrola A; Monreal M; Sevilla M; Goñi MJ; Yoldi A; Terán D
    J Autoimmun; 1990 Oct; 3(5):625-38. PubMed ID: 2252531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of insulin therapy on the immune status of patients with newly detected diabetes mellitus].
    Sliusarenko NS; Taranova NB
    Lik Sprava; 1994; (3-4):102-3. PubMed ID: 7975524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity in patients with newly detected insulin-dependent diabetes mellitus].
    Dedov II; Chugunova LA; Smirnova OM; Brykova SV; Shchegol'kova TS
    Probl Endokrinol (Mosk); 1994; 40(1):17-20. PubMed ID: 8165207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus.
    Gabbay MA; Sato MN; Finazzo C; Duarte AJ; Dib SA
    Arch Pediatr Adolesc Med; 2012 Jul; 166(7):601-7. PubMed ID: 22751874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of a series of parameters of cellular and humoral immunity in patients with diabetes mellitus type I].
    Pometkin VV; Nikonova TV; Brykova SV
    Probl Endokrinol (Mosk); 1994; 40(6):5-7. PubMed ID: 7740039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients.
    ten Berge RJ; Schellekens PT; Surachno S; The TH; ten Veen JH; Wilmink JM
    Clin Immunol Immunopathol; 1981 Oct; 21(1):20-32. PubMed ID: 7023763
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic characterization of patients with insulin-dependent diabetes mellitus with varying duration of disease].
    Shishko PI; Dreval' AV; Sadykova RE; Efuni SS; Matiukov Ae; Abugova IA; Polianskaia IS; Skuĭbin BG; Filatov AV
    Probl Endokrinol (Mosk); 1993; 39(1):8-11. PubMed ID: 8058669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro.
    Röllinghoff M; Schrader J; Wagner H
    Clin Exp Immunol; 1973 Oct; 15(2):261-9. PubMed ID: 4543428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship of vascular changes and immune status disorders in patients with diabetes mellitus type 1].
    Garagan SF
    Lik Sprava; 1997; (3):99-103. PubMed ID: 9377367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New data on the effect of azathioprine at the cellular level.
    Galanaud P; Crevon MC; Duclos H; Dormont J
    Adv Nephrol Necker Hosp; 1976; 6():371-82. PubMed ID: 65908
    [No Abstract]   [Full Text] [Related]  

  • 17. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.
    Kissel JT; Lynn DJ; Rammohan KW; Klein JP; Griggs RC; Moxley RT; Cwik VA; Brooke MH; Mendell JR
    Neurology; 1993 Mar; 43(3 Pt 1):532-6. PubMed ID: 8450996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immuno- and regeneration therapy of recently diagnosed diabetes mellitus type I].
    Huth E
    Klin Padiatr; 1985; 197(2):75-84. PubMed ID: 3157826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoregulation in juvenile diabetes].
    Moncada E; Subirá ML; Barbería JJ; Salvador J; Sánchez Ibarrola A; Cano I; Goñi F; Oleaga A
    Rev Clin Esp; 1988 Jun; 183(2):61-6. PubMed ID: 3175165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Introduction to the clinical use of immunosuppressive agents].
    Bach JF
    Ann Med Interne (Paris); 1974 Oct; 125(10):697-702. PubMed ID: 4548812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.